CompletedNot Applicable

Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy

Egypt42 participantsStarted 2019-10-15

Plain-language summary

To evaluate the efficacy and safety of 532 nm green subthreshold micropulse laser (GSML) as a treatment for acute central serous chorioretinopathy (CSCR).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * acute CSCR Exclusion Criteria: * chronic CSCR Previously treated case of Acute CSCR

What they're measuring

change in visual acuity

Timeframe: 18 months

Trial details

NCT IDNCT05447117

SponsorMinia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-30

View on ClinicalTrials.gov More Acute Central Serous Retinopathy With Subretinal Fluid trials